Profile	GDS4460 / 203373_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	255	82
GSM803589	patient 7, baseline	183.7	77
GSM803592	patient 8, baseline	233	81
GSM803595	patient 10, baseline	217.6	79
GSM803598	patient 11, baseline	129.2	72
GSM803601	patient 12, baseline	243.8	81
GSM803604	patient 13, baseline	235.7	81
GSM803607	patient 14, baseline	236.1	81
GSM803610	patient 15, baseline	163.2	76
GSM803613	patient 16, baseline	125.1	72
GSM803587	patient 6, arm treated with pimecrolimus	183.2	78
GSM803590	patient 7, arm treated with pimecrolimus	239.1	81
GSM803593	patient 8, arm treated with pimecrolimus	171.7	76
GSM803605	patient 13, arm treated with pimecrolimus	169	77
GSM803608	patient 14, arm treated with pimecrolimus	191.6	78
GSM803599	patient 11, arm treated with pimecrolimus	257.5	82
GSM803611	patient 15, arm treated with pimecrolimus	198.4	78
GSM803614	patient 16, arm treated with pimecrolimus	166.3	76
GSM803602	patient 12, arm treated with pimecrolimus	188.6	78
GSM803596	patient 10, arm treated with pimecrolimus	190.2	77
GSM803591	patient 8, arm treated with betamethasone	147.3	74
GSM803609	patient 15, arm treated with betamethasone	225.9	80
GSM803597	patient 11, arm treated with betamethasone	217.3	80
GSM803585	patient 6, arm treated with betamethasone	121.3	71
GSM803603	patient 13, arm treated with betamethasone	253.7	82
GSM803612	patient 16, arm treated with betamethasone	176	76
GSM803588	patient 7, arm treated with betamethasone	276.5	83
GSM803594	patient 10, arm treated with betamethasone	177.1	77
GSM803600	patient 12, arm treated with betamethasone	182.3	77
GSM803606	patient 14, arm treated with betamethasone	200.7	79